These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38410343)
1. Over-the-Counter Bronchodilators Use Among Asthmatic Patients in Al-Medina Al-Monawwara. Khalil A; Almouteri MM; Alraddadi SF; Abdullah EA; Aljohani RH; Alhejaily RM Cureus; 2024 Jan; 16(1):e53026. PubMed ID: 38410343 [No Abstract] [Full Text] [Related]
2. The Association Between Short-Acting β Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E; Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584 [TBL] [Abstract][Full Text] [Related]
3. Overprescription of short-acting β Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074 [TBL] [Abstract][Full Text] [Related]
4. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Kew KM; Karner C; Mindus SM; Ferrara G Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671 [TBL] [Abstract][Full Text] [Related]
5. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Fan VS; Gylys-Colwell I; Locke E; Sumino K; Nguyen HQ; Thomas RM; Magzamen S Respir Med; 2016 Jul; 116():100-6. PubMed ID: 27296828 [TBL] [Abstract][Full Text] [Related]
6. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
7. Overprescription of short-acting β Al-Jahdali H; Wali S; Albanna AS; Al Harbi A; Allehebi R; Arwadi A; Dahan T; Fattouh M; Hamza E; Beekman M Clin Respir J; 2022 Dec; 16(12):812-825. PubMed ID: 36279888 [TBL] [Abstract][Full Text] [Related]
8. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639 [TBL] [Abstract][Full Text] [Related]
9. Over-prescription of short-acting β Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290 [TBL] [Abstract][Full Text] [Related]
10. Over-the-counter use of short-acting beta-2 agonists: a systematic review. Loh ZC; Hussain R; Ong SC; Saini B; Muneswarao J; Ur-Rehman A; Babar ZU J Pharm Policy Pract; 2023 Oct; 16(1):119. PubMed ID: 37814312 [TBL] [Abstract][Full Text] [Related]
11. Over-prescription of short-acting β Chakaya J; Mecha J; Beekman M BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638 [TBL] [Abstract][Full Text] [Related]
12. SABA Overuse in Russia - Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study. Avdeev S; Voznesenskiy N; Boldina M; Ignatova G; Kostina N; Kulbaisov A; Leshchenko I; Beekman MJHI J Asthma Allergy; 2022; 15():371-379. PubMed ID: 35368426 [TBL] [Abstract][Full Text] [Related]
13. Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study. Modi M; Mody K; Jhawar P; Sharma L; Padukudru Anand M; Gowda G; Mendiratta M; Kumar S; Nayar S; Manchanda M; Kumari Badam A; Singh M; Siddiqui W; Beekman M J Asthma; 2023 Jul; 60(7):1347-1358. PubMed ID: 36519934 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099 [TBL] [Abstract][Full Text] [Related]
15. Short-acting bronchodilators purchase as a marker for asthma control. Shlomi D; Oberman B; Katz I J Asthma; 2022 Jan; 59(1):206-212. PubMed ID: 33125311 [No Abstract] [Full Text] [Related]
16. 'The blue one takes a battering' why do young adults with asthma overuse bronchodilator inhalers? A qualitative study. Cole S; Seale C; Griffiths C BMJ Open; 2013; 3(2):. PubMed ID: 23427203 [TBL] [Abstract][Full Text] [Related]
17. Over-prescription of short-acting β Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189 [TBL] [Abstract][Full Text] [Related]
19. [Description of the use of inhaled rescue medication in an asthmatic population treated in the Primary Care clinics. UMI-ASMA Study]. de Simón Gutiérrez R; Quijada Monzó Á; Ortiz Jiménez MF Semergen; 2020; 46(8):512-523. PubMed ID: 33239152 [TBL] [Abstract][Full Text] [Related]